Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on September 8, 2026

6 hours ago

Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

6 hours ago

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

6 hours ago

Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program

Indeterminate GlobeNewswire

6 hours ago

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

6 hours ago

TruGolf Announces Binding Distribution MOU with TruGolf Canada Inc. Covering Defined Canadian and Indigenous Market Opportunities

Indeterminate GlobeNewswire

6 hours ago

MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

Indeterminate GlobeNewswire

6 hours ago

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire

6 hours ago

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

6 hours ago

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

Indeterminate GlobeNewswire

6 hours ago

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

6 hours ago

AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group

Indeterminate GlobeNewswire

6 hours ago

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Indeterminate GlobeNewswire

6 hours ago

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

6 hours ago

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

6 hours ago

Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026

Indeterminate GlobeNewswire

6 hours ago

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

6 hours ago

NowVertical Expands Google Cloud Practice into Brazil

Indeterminate GlobeNewswire

6 hours ago

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

6 hours ago

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire